Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study
Authors
Keywords
-
Journal
Clinical and Translational Gastroenterology
Volume 12, Issue 4, Pages e00332
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-04-06
DOI
10.14309/ctg.0000000000000332
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ever-increasing diversity of drug-induced pancreatitis
- (2020) Simcha Weissman et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The global, regional, and national burden of pancreatitis in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Guoqing Ouyang et al. BMC Medicine
- Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics
- (2019) Michiel Dirk Voskuil et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
- (2018) Julien Kirchgesner et al. GASTROENTEROLOGY
- Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
- (2017) Magali Lemaitre et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Canadian Digestive Health Foundation Public Impact Series 5: Pancreatitis in Canada. Incidence, Prevalence, and Direct and Indirect Economic Impact
- (2016) Christopher W Teshima et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Canadian Association of Gastroenterology Position Statement Regarding the Use of Thiopurines for the Treatment of Inflammatory Bowel Disease
- (2016) John K Marshall et al. Canadian Journal of Gastroenterology and Hepatology
- Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
- (2015) Marieke J.H. Coenen et al. GASTROENTEROLOGY
- Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
- (2015) Joana Torres et al. GASTROENTEROLOGY
- Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
- (2015) Brian Bressler et al. GASTROENTEROLOGY
- Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity
- (2015) Niels Teich et al. Journal of Crohns & Colitis
- HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants
- (2014) Graham A Heap et al. NATURE GENETICS
- American College of Gastroenterology Guideline: Management of Acute Pancreatitis
- (2013) Scott Tenner et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease
- (2013) Jonathan P. Terdiman et al. GASTROENTEROLOGY
- Safety of Thiopurine Therapy in Inflammatory Bowel Disease
- (2013) María Chaparro et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started